- Home
- LSTA vs NNVC Comparison
LSTA vs NNVC Comparison
Compare LSTA & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- NNVC
- Stock Information
- Founded
- LSTA 1980
- NNVC 2005
- Country
- LSTA United States
- NNVC United States
- Employees
- LSTA N/A
- NNVC N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- NNVC Biotechnology: Pharmaceutical Preparations
- Sector
- LSTA Health Care
- NNVC Health Care
- Exchange
- LSTA Nasdaq
- NNVC Nasdaq
- Market Cap
- LSTA 20.9M
- NNVC 23.1M
- IPO Year
- LSTA N/A
- NNVC N/A
- Fundamental
- Price
- LSTA $2.44
- NNVC $1.53
- Analyst Decision
- LSTA Strong Buy
- NNVC
- Analyst Count
- LSTA 2
- NNVC 0
- Target Price
- LSTA $23.50
- NNVC N/A
- AVG Volume (30 Days)
- LSTA 43.5K
- NNVC 152.6K
- Earning Date
- LSTA 11-11-2025
- NNVC 11-13-2025
- Dividend Yield
- LSTA N/A
- NNVC N/A
- EPS Growth
- LSTA N/A
- NNVC N/A
- EPS
- LSTA N/A
- NNVC N/A
- Revenue
- LSTA $1,070,000.00
- NNVC N/A
- Revenue This Year
- LSTA N/A
- NNVC N/A
- Revenue Next Year
- LSTA N/A
- NNVC $133.33
- P/E Ratio
- LSTA N/A
- NNVC N/A
- Revenue Growth
- LSTA N/A
- NNVC N/A
- 52 Week Low
- LSTA $1.87
- NNVC $0.94
- 52 Week High
- LSTA $4.20
- NNVC $1.92
- Technical
- Relative Strength Index (RSI)
- LSTA 49.36
- NNVC 60.59
- Support Level
- LSTA $2.35
- NNVC $1.30
- Resistance Level
- LSTA $2.61
- NNVC $1.46
- Average True Range (ATR)
- LSTA 0.16
- NNVC 0.07
- MACD
- LSTA -0.00
- NNVC 0.01
- Stochastic Oscillator
- LSTA 35.71
- NNVC 68.18
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
About NNVC NanoViricides Inc.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.